![]() |
![]() scientific design, conduct, analysis & reporting of clinical trials |
|||||||||||||||||||||||||||||
|
Lagakos' Symposium
"Impact of Biostatistical Science - Advances in Research: AIDS, Cancer, Environment"
Urania Dafni Urania Dafni, is Professor and Director of the Laboratory of Biostatistics at the University of Athens Department of Nursing and the Vice President and Director of Frontier Science Foundation – Hellas (FSF-H). She holds a Science Doctorate from the Department of Biostatistics, Harvard School of Public Health. She has been one of the founding members of the Eastern Mediterranean Region of the International Biometric Society (EMR-IBS; 2001-present) and President of EMR-IBS (2005-2007). In 2008, she received a Recognition Award from the International Biometric Society (IBS) for Outstanding Dedication and Exemplary Service as Biometric Bulletin Editor, 2005-2008, and she is currently a member of the Executive Committee of IBS (2007-2010). She has served as the scientific director of the National Syndromic Surveillance program for the Athens 2004 Olympic games and currently participates in the European Community Grant on Syndromic Surveillance (Triple S-AGE) . She is an Associate Editor of the on line journal Advances in Disease Surveillance, and reviewer of several scientific journals. She is a member of the BoD of the National Network for the Prevention of Accidents and Violence. She has been a member of the organizing and/or scientific committee of international conferences (XXIIIrd IBS International Conference, 2006; International Society for Clinical Biostatistics - ISCB28, 2007) and chair of the 3rd EMR-IBS conference (2005). She has published over 90 papers in high impact peer-reviewed international journals (including Biometrics, JASA, NEJM, JCO, MMWR, J Intern Med, Arthritis Rheum, Control Clin Trials). She has participated in numerous Clinical Trials mainly in Cancer, AIDS, and auto-immune diseases and her research interests include surrogate markers, multivariate count data, adaptive study design and methods accounting for crossover.
Frontier Science Foundation-Hellas 2007-2011 |
|||||||||||||||||||||||||||||